Application of the apoptogenic pretreatment to enhance the anti-tumor immunity of the Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)-secreting CT26 tumor cells
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background: As an attempt to develop a strategy to improve the protective immune response to GM-CSF-secreting CT26 (GM-CSF/CT26) tumor vaccine, we have investigated whether the apoptogenic treatment of GM-CSF/CT26 prior to vaccination enhances the induction of anti-tumor immune response in mouse model. Methods: A carcinogen- induced mouse colorectal tumor, CT26 was transfected with GM-CSF gene using a retroviral vector to generate GM-CSF-secreting CT26 (CT26/GM-CSF). The CT26/GM-CSF was treated with γ-irradiation or mitomycin C to induce apoptosis and vaccinated into BALB/c mice. After 7 days, the mice were injected with a lethal dose of challenge live CT26 cells to examine the protective effect of tumor vaccination in vivo. Results: Although both apoptotic and necrotic CT26/GM-CSF vaccines were able to enhance anti-tumor immune response, apoptotic CT26/GM-CSF induced by pretreatment with γ-irradiation (50,000 rads) was the most potent in generating the anti-tumor immunity, and thus 100% of mice vaccinated with the apoptotic cells remained tumor free for more than 60 days after tumor challenge. Conclusion: Apoptogenic pretreatment of GM-CSF-secreting CT26 tumor vaccine by γ-irradiation (50,000 rads) resulted in a significant enhancement in inducing the protective anti-tumor immunity. A rapid induction of apoptosis of CT26/GM-CSF tumor vaccine at the vaccine site might be critical for the enhancement in anti-tumor immune response to tumor vaccine.
참고문헌 (26)
- "Interleukin-2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity", 172, pp.1217~1224 (1990)
- "Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent", dra(ff g), pp.3539~3543 (1993)
- "Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony- stimulating factor gene transfer", 57, pp.1537~1546 (1997)
- "Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony- stimulating factor generates potent antitumor immunity in patient with meastatic melanoma", 95, pp.13141~13146 (1998)
- "Induction of immunity to prostate cancer antigens results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer", 59, pp.5160~5168 (1999)
- "Novel allogenic granulocyte- macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer a phase 1 trial of safety and immune activation", 19, pp.145~156 (2001)
- "A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin", pp.313~337 (2004)
- "Antibodies to CD3", T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures, 1989, pp.337, 181~184
- "Cell death induction by receptors of the TNF family:towards a molecular understanding", 410, pp.96~106 (1997)
- "Autocrine T-cell suicide mediated by APO-1", (Fas, pp.1995, 373[DOI]
- "Oxidative stress as a mediator of apoptosis", 15, pp.7~10 (1994)
- "Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen- activated protein kinase", 272, pp.20490~20494 (1997)
- "Heat shock induces apoptosis in mouse thymocytes and protects them from glucocorticoid-induced cell death", 143, pp.348~356 (1992)
- "UV radiation induces DNA fragmentation and cell death in B16 melanoma sensitized by bromodeoxyuridine:impaired c-jun induction and defective tyrosine phosphorylation signalling", 203, pp.1629~1637 (1994)
- "Apoptosis and dilemma of cancer chemotherapy", 89, pp.1845~1853 (1997)
- "The induction of tolerance by dendritic cells that have captured apoptotic cells", 191, pp.411~416 (2000)
- "Bystander apoptosis triggers dentritic cell maturation and antigen-presenting function", 161, pp.4467~4471 (1998)
- "tumor cells vaccines induce a potent immune response in vivo", 103, pp.205~211 (2003)
- "Enhanced expression of Fas ligand is associated with aburatubolactam C-induced apoptosis in human Jurkat T cells", 246, pp.276~281 (1998)
- "Cancer vaccine", 17, pp.1047~1060 (1999)
- "Consequences of cell death Exposure to necrotic tumor cells but not primary tissue cells or apoptotic cells induces the maturation of immunostimulatory dendritic cells", 191, pp.423~434 (2000)
- "Tumor antigens recognized by T cells", 18, pp.267~268 (1997)
- "identification of human tumor antigen by SEREX", 6, pp.208~217 (2000)
- "Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines", 59, pp.3329~3332 (1999)
- "Therapy of established tumor with a hybrid cellular vaccine generated by using granulocyte-macrophage colony- stimulating factor genetically modified dendritic cells", 97, pp.616~625 (1999)
- "Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL", 6 mice, 1984, pp.35, 2434~2439
